Cardiorespiratory effects of gamma-hydroxybutyric acid during isoflurane anaesthesia in pigs
Veterinary Anaesthesia and Analgesia · 2025
DOI: 10.1016/j.vaa.2024.10.135 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Anaesthesia and Analgesia, 2025. Verfasst von Charlotte Cuypers und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Large Animal Surgery, Anaesthesia and Orthopaedics, Ghent University, Merelbeke, Belgium. Electronic address: charlottem.cuypers@ugent.…. Hauptthemen laut MEDLINE: Isoflurane, Anesthetics, Inhalation, Cross-Over Studies, Heart Rate. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: To investigate the haemodynamic effects of gamma-hydroxybutyric acid (GHB) in isoflurane-anaesthetized pigs. STUDY DESIGN: Experimental, randomized, nonblinded, crossover study. ANIMALS: A group of six stress-resistant Landrace pigs (approximately 3 months old; three male, three female; bodyweight 39.2 ± 4 kg, mean ± standard deviation). METHODS: After premedication (midazolam 0.5 mg kg-1 and ketamine 10 mg kg-1 intramuscularly) and induction [propofol 0.25-0.5 mg kg-1 intravenously (IV)], anaesthesia was maintained with isoflurane in oxygen, and either GHB 250 mg kg-1 IV or an equal volume of saline was administered (minimum washout period 1 week). Systolic (SAP), diastolic (DAP) and mean (MAP) arterial pressures, heart rate and rhythm and respiratory rate were recorded every 5 minutes for 2 hours. Arterial samples were collected for blood gas and pharmacokinetic analyses. Relative changes from baseline were calculated and compared between treatments using a mixed model with time, period and treatment as variables (α < 0.05). RESULTS: Changes from baseline differed significantly between treatments (p < 0.001) for SAP (GHB -1.6 ± 10.7; saline -5.9 ± 14.8 mmHg), DAP (GHB +2.9 ± 9.6; saline -6.5 ± 10.7 mmHg) and MAP (GHB +2.2 ± 10.5; saline -5.7 ± 9.6 mmHg). Statistical analysis of secondary outcomes suggested effects on PaO2 [GHB -45.2 ± 29.8 mmHg (-6.03 ± 3.97 kPa); saline +24.5 ± 32.4 mmHg (+3.27 ± 4.32 kPa); p < 0.001] and PaCO2 [GHB -2 ± 10 mmHg (-0.27 ± 1.33 kPa); saline -9 ± 8 mmHg (-1.20 ± 1.07 kPa); p < 0.001]. Mean maximum blood concentration of GHB was 1171.1 ± 229.3 μg mL-1, with volume of distribution 335.3 ± 68.5 mL kg-1, clearance 77.2 ± 19.12 mL kg-1 hour-1 and elimination half-life 3.10 ± 0.80 hours. CONCLUSIONS AND CLINICAL RELEVANCE: GHB did not cause severe physiological side effects and may reduce cardiovascular depression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Large Animal Surgery, Anaesthesia and Orthopaedics, Ghent University, Merelbeke, Belgium. Electronic address: charlottem.cuypers@ugent.be.
- Department of Pathobiology, Pharmacology and Zoological Medicine, Ghent University, Merelbeke, Belgium.
- Department of Laboratory of Toxicology, Ghent University, Ghent, Belgium.
- Department of Internal Medicine, Reproduction and Population Medicine, Ghent University, Merelbeke, Belgium.
- Department of Large Animal Surgery, Anaesthesia and Orthopaedics, Ghent University, Merelbeke, Belgium.
Zitieren
APA
Cuypers, C., Devreese, M., Van Uytfanghe, K., Stove, C., Van Steenkiste, G., & Schauvliege, S. (2025). Cardiorespiratory effects of gamma-hydroxybutyric acid during isoflurane anaesthesia in pigs. Veterinary Anaesthesia and Analgesia. https://doi.org/10.1016/j.vaa.2024.10.135
Vancouver
Cuypers C, Devreese M, Van Uytfanghe K, Stove C, Van Steenkiste G, Schauvliege S. Cardiorespiratory effects of gamma-hydroxybutyric acid during isoflurane anaesthesia in pigs. Veterinary Anaesthesia and Analgesia. 2025. doi:10.1016/j.vaa.2024.10.135
BibTeX
@article{Cuypers2025,
author = {Cuypers, Charlotte and Devreese, Mathias and Van Uytfanghe, Katleen and Stove, Christophe and Van Steenkiste, Glenn and Schauvliege, Stijn},
title = {Cardiorespiratory effects of gamma-hydroxybutyric acid during isoflurane anaesthesia in pigs},
journal = {Veterinary Anaesthesia and Analgesia},
year = {2025},
doi = {10.1016/j.vaa.2024.10.135}
}
EUVIMED